BIOCARDIA INC (BCDA)

US09060U6064 - Common Stock

2.16  -0.09 (-4%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
1.02M
580.00%
1.35M
32.35%
477K
-64.67%
102K
-78.62%
102K102K102K8.568M
8,300.00%
EBITDA
YoY % growth
-12.57M
18.69%
-11.82M
5.97%
-11.56M
2.20%
-9.894M
14.41%
-11.22M
-13.40%
-13.362M
-19.09%
-16.422M
-22.90%
-14.484M
11.80%
EBIT
YoY % growth
-12.63M
18.67%
-11.9M
5.78%
-11.644M
2.15%
-9.894M
15.03%
-11.22M
-13.40%
-13.362M
-19.09%
-16.422M
-22.90%
-14.484M
11.80%
Operating Margin
-1,238.24%-881.48%-2,441.09%-9,700.00%-11,000.00%-13,100.00%-16,100.00%-169.05%
EPS
YoY % growth
-11.10
53.16%
-10.05
9.46%
-8.25
17.91%
-3.59
56.48%
-1.24
65.34%
-1.36
-9.02%
-1.45
-6.77%
-1.05
27.46%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-0.89
34.27%
Revenue
Q2Q % growth
20.4K
56.92%
EBITDA
Q2Q % growth
-4.08M
-104.00%
EBIT
Q2Q % growth
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.61
66.11%
-1.210.6049.74%
Q2 2024
Q2Q % growth

92.00%
-0.20%
Q1 2024
Q2Q % growth
-0.09
96.47%
-0.200.1155.88%
Q4 2023
Q2Q % growth
-1.35
43.75%
-1.680.3319.79%
Q3 2023
Q2Q % growth
-1.80
29.41%
-1.840.041.96%
Q2 2023
Q2Q % growth
-2.55
-21.43%
-2.40-0.15-6.38%
Q1 2023
Q2Q % growth
-2.55
15.00%
-2.45-0.10-4.17%
Q4 2022
Q2Q % growth
-2.40
20.00%
-2.750.3512.85%
Q3 2022
Q2Q % growth
-2.55
-6.25%
-3.520.9727.54%
Q2 2022
Q2Q % growth
-2.10
30.00%
-3.791.6944.66%
Q1 2022
Q2Q % growth
-3.00
-11.11%
-3.620.6217.15%
Q4 2021
Q2Q % growth
-3.00
-33.33%
-3.170.175.50%
Q3 2021
Q2Q % growth
-2.40
46.67%
-3.210.8125.30%
Q2 2021
Q2Q % growth
-3.00
56.52%
-3.060.061.96%
Q1 2021
Q2Q % growth
-2.70
73.13%
-3.751.0527.97%
Q4 2020
Q2Q % growth
-2.25
68.75%
-4.542.2950.43%
Q3 2020
Q2Q % growth
-4.50 -4.32-0.18-4.11%
Q2 2020
Q2Q % growth
-6.90 -3.52-3.38-96.08%
Q1 2020
Q2Q % growth
-10.05 -6.27-3.78-60.21%
Q4 2019
Q2Q % growth
-7.20 -7.800.607.73%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth

-100.00%
204K-204K-100.00%
Q2 2024
Q2Q % growth
3K
-93.02%
%
Q1 2024
Q2Q % growth
60K
-6.25%
%
Q4 2023
Q2Q % growth
13K
-88.18%
96.9K-83.9K-86.58%
Q3 2023
Q2Q % growth
357K
70.00%
25.5K331.5K1,300.00%
Q2 2023
Q2Q % growth
43K
-95.57%
124.777K-81.777K-65.54%
Q1 2023
Q2Q % growth
64K
6.67%
346.8K-282.8K-81.55%
Q4 2022
Q2Q % growth
110K
37.50%
104.04K5.96K5.73%
Q3 2022
Q2Q % growth
210K
-74.39%
76.837K133.163K173.31%
Q2 2022
Q2Q % growth
970K
1,285.71%
95.88K874.12K911.68%
Q1 2022
Q2Q % growth
60K
20.00%
132.6K-72.6K-54.75%
Q4 2021
Q2Q % growth
80K
60.00%
43.605K36.395K83.47%
Q3 2021
Q2Q % growth
820K
2,633.33%
15.3K804.7K5,259.48%
Q2 2021
Q2Q % growth
70K
133.33%
22.777K47.223K207.33%
Q1 2021
Q2Q % growth
50K
25.00%
35.7K14.3K40.06%
Q4 2020
Q2Q % growth
50K
-77.27%
30.6K19.4K63.40%
Q3 2020
Q2Q % growth
30K
-84.21%
63.495K-33.495K-52.75%
Q2 2020
Q2Q % growth
30K
-66.67%
182.58K-152.58K-83.57%
Q1 2020
Q2Q % growth
40K
-81.82%
168.3K-128.3K-76.23%
Q4 2019
Q2Q % growth
220K 123.93K96.07K77.52%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -625% 0% 30.43%
Revenue0% N/A -80% -80%